Evidence map›Paper›PMID 23055491›Full record

ArticleThe Journal of neuroscience : the official journal of the Society for Neuroscience2012

Central amygdala metabotropic glutamate receptor 5 in the modulation of visceral pain.

Lara W Crock, Benedict J Kolber, Clinton D Morgan, Katelyn E Sadler, Sherri K Vogt, Michael R Bruchas, Robert W Gereau

Open access · bronzeAbstract read
In one paragraph

Article in The Journal of neuroscience : the official journal of the Society for Neuroscience, 2012. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 56 papers.

0numbers the graph read from it
0cells of the map it votes in
56citing papers in PubMed
4.6field-weighted citation impact, top 5% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

56 citing papers in PubMed, 111 citations in OpenAlex.

  1. Trial
  2. Article
  3. Article
  4. Article
  5. Review
  6. Article
  7. Article
  8. Article
  9. Article
  10. Review
  11. Review
  12. Article
  13. Review
  14. Article
  15. Review
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 2 institutions in 1 country.

Lara W CrockProgram in Neuroscience, Department of Anesthesiology, Washington University School of Medicine, St. Louis, Missouri 63110, USA.
Benedict J Kolber
Clinton D Morgan
Katelyn E Sadler
Sherri K Vogt
Michael R Bruchas
Robert W Gereau
Washington University in St. Louis · USDuquesne University · US

Funding

Washington University MAPP Network Discovery SiteU01DK082315 · NIDDK · WASHINGTON UNIVERSITY · PI LAI, HING HUNG HENRY · 2008 to 2021
$9.0M
MECHANISMS OF CENTRAL SENSITIZATIONR01NS048602 · NINDS · WASHINGTON UNIVERSITY · PI GEREAU, ROBERT W · 2004 to 2014
$4.2M
Opioid and Noradrenergic Mechanisms in Stress and Drug SeekingR00DA025182 · NIDA · WASHINGTON UNIVERSITY · PI BRUCHAS, MICHAEL R. · 2011 to 2013
$723k
Cellular and molecular mechanisms undelying amygdala-dependent pain modulationF32NS067761 · NINDS · WASHINGTON UNIVERSITY · PI KOLBER, BENEDICT J · 2010 to 2011
$91k
The Role of Metabotropic Glutamate Receptor 5 in Bladder PainF30DK089969 · NIDDK · WASHINGTON UNIVERSITY · PI CROCK, LARA WILEY · 2010 to 2012
$80k
NIDA NIH HHS R00 DA025182NIDA NIH HHS R00DA025182NIDDK NIH HHS DK82315NIDDK NIH HHS F30 DK089969NIDDK NIH HHS F30 DK089969-02NIDDK NIH HHS U01 DK082315NINDS NIH HHS F32 NS067761NINDS NIH HHS R01 NS048602NINDS NIH HHS R01 NS48602
6 · The paper itself

Abstract

Painful bladder syndrome is a debilitating condition that affects 3-6% of women in the United States. Multiple lines of evidence suggest that changes in CNS processing are key to the development of chronic bladder pain conditions but little is known regarding the underlying cellular, molecular, and neuronal mechanisms. Using a mouse model of distention-induced bladder pain, we found that the central nucleus of the amygdala (CeA) is a critical site of neuromodulation for processing of bladder nociception. Furthermore, we demonstrate that metabotropic glutamate receptor 5 (mGluR5) activation in the CeA induces bladder pain sensitization by increasing CeA output. Thus, pharmacological activation of mGluR5 in the CeA is sufficient to increase the response to bladder distention. Additionally, pharmacological blockade or virally mediated conditional deletion of mGluR5 in the CeA reduced responses to bladder distention suggesting that mGluR5 in the CeA is also necessary for these responses. Finally, we used optogenetic activation of the CeA and demonstrated that this caused a robust increase in the visceral pain response. The CeA-localized effects on responses to bladder distention are associated with changes in extracellular signal-regulated kinases 1/2 (ERK1/2) phosphorylation in the spinal cord. Overall, these data demonstrate that mGluR5 activation leads to increased CeA output that drives bladder pain sensitization.

Indexed as

AmygdalaAnimalsFemaleMAP Kinase Signaling SystemMiceMice, Inbred C57BLMice, KnockoutPain MeasurementReceptor, Metabotropic Glutamate 5Receptors, Metabotropic GlutamateVisceral PainGrm5 protein, mouseReceptor, Metabotropic Glutamate 5Receptors, Metabotropic Glutamate

Identifiers

PMID23055491
PMCPMC3494864
OpenAlexW2136408513

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.